H. Inami

发表

Renoprotective effects of novel interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 through anti-inflammatory action in 5/6 nephrectomized rats

K. Hayashi, T. Ishikawa, Masaki Abe, 2014, Naunyn-Schmiedeberg's Archives of Pharmacology.

Design and synthesis of 6-fluoro-2-naphthyl derivatives as novel CCR3 antagonists with reduced CYP2D6 inhibition.

M. Takeuchi, Keiko Suzuki, M. Ohta, 2008, Bioorganic & medicinal chemistry.

Synthesis, biological evaluation, and metabolic stability of acrylamide derivatives as novel CCR3 antagonists.

K. Ohno, M. Takeuchi, Keiko Suzuki, 2009, Bioorganic & medicinal chemistry.

Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists.

M. Takeuchi, Keiko Suzuki, M. Ohta, 2008, Bioorganic & medicinal chemistry.

Effects of 2-[N-(4-Chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an Orally Active α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonist, in Models of Generalized Epileptic Seizure in Mice and Rats

H. Yamashita, Tokio Yamaguchi, M. Okada, 2004, Journal of Pharmacology and Experimental Therapeutics.

Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in rats

H. Yamashita, Tokio Yamaguchi, M. Okada, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Suppression of fully kindled seizure and retardation of kindling acquisition by YM928 in the rat kindling model of epilepsy.

H. Yamashita, Tokio Yamaguchi, M. Okada, 2004, European journal of pharmacology.

A regiochemical control in the π-allylpalladium substitution. Preparation of optically active γ-silylallylamines

T. Ito, F. Sato, H. Urabe, 1993 .

Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4H-pyrido[3,2-e][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor Antagonists.

H. Yamashita, M. Hirano, T. Yasunaga, 2019, Chemical & pharmaceutical bulletin.

Regio- and stereo-controlled methylation of γ-silylallyl phosphates by π-allylpalladium methodology

F. Sato, H. Urabe, H. Inami, 1993 .

A novel class of inhibitors for human and rat steroid 5alpha-reductases: synthesis and biological evaluation of indoline and aniline derivatives. III.

T. Mase, H. Oritani, H. Koutoku, 2000, Chemical & pharmaceutical bulletin.

A novel class of inhibitors for human steroid 5alpha-reductase: synthesis and biological evaluation of indole derivatives. II.

T. Mase, H. Oritani, H. Koutoku, 2000, Chemical & pharmaceutical bulletin.

A Novel Class of Inhibitors for Human and Rat Steroid 5α‐Reductases: Synthesis and Biological Evaluation of Indoline and Aniline Derivatives. Part 3.

T. Mase, H. Oritani, H. Koutoku, 2001 .

A Novel Class of Inhibitors for Human Steroid 5α-Reductase: Synthesis and Biological Evaluation of Indole Derivatives. Part 2.

T. Mase, H. Oritani, H. Koutoku, 2000 .

In‐vitro Characterization of YM872, a Selective, Potent and Highly Water‐soluble α‐Amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionate Receptor Antagonist

R. Tsutsumi, A. Kohara, Tokio Yamaguchi, 1998, The Journal of pharmacy and pharmacology.

Renoprotective effects of novel interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 through anti-inflammatory action in 5/6 nephrectomized rats

K. Hayashi, T. Ishikawa, Masaki Abe, 2014, Naunyn-Schmiedeberg's Archives of Pharmacology.

Therapeutic effects of interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 on diabetic nephropathy in type 2 diabetic mice

K. Hayashi, T. Ishikawa, M. Kondo, 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.

Anti-Inflammatory Profile of AS2444697, A Novel Interleukin-1 Receptor-Associated Kinase-4 Inhibitor

T. Kontani, E. Imamura, Y. Shimizu, 2011 .

Functional Characterization of YM928, a Novel Noncompetitive AMPA Receptor Antagonist

N. Matsumoto, R. Tsutsumi, M. Okada, 2003 .

Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists.

H. Yamashita, T. Yasunaga, S. Sakamoto, 2015, Bioorganic & medicinal chemistry.

Corrigendum to “Synthesis and structure–activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists” [Bioorg. Med. Chem. 16 (2008) 144–156]

M. Takeuchi, Keiko Suzuki, M. Ohta, 2008 .

Design, synthesis, and pharmacological evaluation of N-(3-carbamoyl-1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide derivatives as interleukin-1 receptor-associated kinase 4 inhibitors with reduced potential for cytochrome P450 1A2 induction.

T. Kontani, E. Imamura, T. Ishikawa, 2023, Bioorganic & medicinal chemistry.